DOI QR코드

DOI QR Code

Presentation of Neurolytic Effect of 10% Lidocaine after Perineural Ultrasound Guided Injection of a Canine Sciatic Nerve: A Pilot Study

  • Kim, David D (Department of Anesthesiology, Henry Ford Hospital) ;
  • Asif, Asma (Department of Anesthesiology, Henry Ford Hospital) ;
  • Kataria, Sandeep (Department of Anesthesiology, Henry Ford Hospital)
  • Received : 2016.03.21
  • Accepted : 2016.06.01
  • Published : 2016.07.01

Abstract

Background: Phenol and alcohol have been used to ablate nerves to treat pain but are not specific for nerves and can damage surrounding soft tissue. Lidocaine at concentrations > 8% injected intrathecal in the animal model has been shown to be neurotoxic. Tests the hypothesis that 10% lidocaine is neurolytic after a peri-neural blockade in an ex vivo experiment on the canine sciatic nerve. Methods: Under ultrasound, one canine sciatic nerve was injected peri-neurally with 10 cc saline and another with 10 cc of 10% lidocaine. After 20 minutes, the sciatic nerve was dissected with gross inspection. A 3 cm segment was excised and preserved in 10% buffered formalin fixative solution. Both samples underwent progressive dehydration and infusion of paraffin after which they were placed on paraffin blocks. The sections were cut at $4{\mu}m$ and stained with hemoxylin and eosin. Microscopic review was performed by a pathologist from Henry Ford Hospital who was blinded to which experimental group each sample was in. Results: The lidocaine injected nerve demonstrated loss of gross architecture on visual inspection while the saline injected nerve did not. No gross changes were seen in the surrounding soft tissue seen in either group. The lidocaine injected sample showed basophilic degeneration with marked cytoplasmic vacuolation in the nerve fibers with separation of individual fibers and endoneurial edema. The saline injected sample showed normal neural tissue. Conclusions: Ten percent lidocaine causes rapid neurolytic changes with ultrasound guided peri-neural injection. The study was limited by only a single nerve being tested with acute exposure.

Keywords

References

  1. Gregg RV, Costantini CH, Ford DJ, Raj PP. Electrophysiological investigation of alcohol as a neurolytic agent. Anesthesiology 1985; 63: A250. https://doi.org/10.1097/00000542-198509001-00250
  2. Kennedy WF Jr, Akamatsu T. Subarachnoid block with phenol-glycerine for the relief of intractable pain. Anesthesiology 1963; 24: 584-5. https://doi.org/10.1097/00000542-196307000-00021
  3. Moritz U. Phenol block of peripheral nerves. Scand J Rehabil Med 1973; 5: 160-3.
  4. Wood KM. The use of phenol as a neurolytic agent: a review. Pain 1978; 5: 205-29. https://doi.org/10.1016/0304-3959(78)90009-X
  5. Westerlund T, Vuorinen V, Kirvela O, Roytta M. The endoneurial response to neurolytic agents is highly dependent on the mode of application. Reg Anesth Pain Med 1999; 24: 294-302. https://doi.org/10.1097/00115550-199924040-00004
  6. Fujita Y. CT-guided neurolytic splanchnic nerve block with alcohol. Pain 1993; 55: 363-6. https://doi.org/10.1016/0304-3959(93)90012-E
  7. LeBlanc JK, Al-Haddad M, McHenry L, Sherman S, Juan M, McGreevy K, et al. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc 2011; 74: 1300-7. https://doi.org/10.1016/j.gie.2011.07.073
  8. Kitoh T, Tanaka S, Ono K, Ohfusa Y, Ina H, Otagiri T. Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer pain. J Anesth 2005; 19: 328-32. https://doi.org/10.1007/s00540-005-0342-0
  9. Chua KS, Kong KH. Alcohol neurolysis of the sciatic nerve in the treatment of hemiplegic knee flexor spasticity: clinical outcomes. Arch Phys Med Rehabil 2000; 81: 1432-5. https://doi.org/10.1053/apmr.2000.9395
  10. Kong KH, Chua KS. Outcome of obturator nerve block with alcohol for the treatment of hip adductor spasticity. Int J Rehabil Res 1999; 22: 327-9. https://doi.org/10.1097/00004356-199912000-00011
  11. Swerlow M. Complications of neurolytic neural blockade. In: Neural blockade in clinical anesthesia and management of pain. 2nd ed. Edited by Cousins MJ, Bridenbaugh PO. Philadelphia (PA), Lippincott. 1988, pp 719-35.
  12. Reid W, Watt JK, Gray TG. Phenol injection of the sympathetic chain. Br J Surg 1970; 57: 45-50. https://doi.org/10.1002/bjs.1800570111
  13. Elovic EP, Esquenazi A, Alter KE, Lin JL, Alfaro A, Kaelin DL. Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity. PM R 2009; 1: 842-51. https://doi.org/10.1016/j.pmrj.2009.08.001
  14. Kapur E, Vuckovic I, Dilberovic F, Zaciragic A, Cosovic E, Divanovic KA, et al. Neurologic and histologic outcome after intraneural injections of lidocaine in canine sciatic nerves. Acta Anaesthesiol Scand 2007; 51: 101-7. https://doi.org/10.1111/j.1399-6576.2006.01169.x
  15. Hashimoto K, Sakura S, Bollen AW, Ciriales R, Drasner K. Comparative toxicity of glucose and lidocaine administered intrathecally in the rat. Reg Anesth Pain Med 1998; 23: 444-50.
  16. Kalichman MW, Moorhouse DF, Powell HC, Myers RR. Relative neural toxicity of local anesthetics. J Neuropathol Exp Neurol 1993; 52: 234-40. https://doi.org/10.1097/00005072-199305000-00007
  17. Kanai Y, Katsuki H, Takasaki M. Graded, irreversible changes in crayfish giant axon as manifestations of lidocaine neurotoxicity in vitro. Anesth Analg 1998; 86: 569-73. https://doi.org/10.1213/00000539-199803000-00025
  18. Ready LB, Plumer MH, Haschke RH, Austin E, Sumi SM. Neurotoxicity of intrathecal local anesthetics in rabbits. Anesthesiology 1985; 63: 364-70. https://doi.org/10.1097/00000542-198509001-00364
  19. Lambert LA, Lambert DH, Strichartz GR. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology 1994; 80: 1082-93. https://doi.org/10.1097/00000542-199405000-00017
  20. Bainton CR, Strichartz GR. Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve. Anesthesiology 1994; 81: 657-67. https://doi.org/10.1097/00000542-199409000-00020
  21. Lirk P, Flatz M, Haller I, Hausott B, Blumenthal S, Stevens MF, et al. In Zucker diabetic fatty rats, subclinical diabetic neuropathy increases in vivo lidocaine block duration but not in vitro neurotoxicity. Reg Anesth Pain Med 2012; 37: 601-6. https://doi.org/10.1097/AAP.0b013e3182664afb
  22. Farber SJ, Saheb-Al-Zamani M, Zieske L, Laurido-Soto O, Bery A, Hunter D, et al. Peripheral nerve injury after local anesthetic injection. Anesth Analg 2013; 117: 731-9. https://doi.org/10.1213/ANE.0b013e3182a00767
  23. Yang S, Abrahams MS, Hurn PD, Grafe MR, Kirsch JR. Local anesthetic Schwann cell toxicity is time and concentration dependent. Reg Anesth Pain Med 2011; 36: 444-51. https://doi.org/10.1097/AAP.0b013e318228c835
  24. Perez-Castro R, Patel S, Garavito-Aguilar ZV, Rosenberg A, Recio-Pinto E, Zhang J, et al. Cytotoxicity of local anesthetics in human neuronal cells. Anesth Analg 2009; 108: 997-1007. https://doi.org/10.1213/ane.0b013e31819385e1
  25. Myers RR, Heckman HM. Effects of local anesthesia on nerve blood flow: studies using lidocaine with and without epinephrine. Anesthesiology 1989; 71: 757-62. https://doi.org/10.1097/00000542-198911000-00021
  26. Johnson ME, Uhl CB. Toxic elevation of cytoplasmic calcium by high lidocaine in a neuronal cell line. Reg Anesth 1997; 22: S68.
  27. Johnson ME, Uhl CB, Saenz JA, Dasilva AD. Lidocaine is more neurotoxic than bupivacaine, with a different mechanism of cytoplasmic calcium elevation. Reg Anesth 1998; 23: S30.
  28. Schneider M, Ettlin T, Kaufmann M, Schumacher P, Urwyler A, Hampl K, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154-7.
  29. Keld DB, Hein L, Dalgaard M, Krogh L, Rodt SA. The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand 2000; 44: 285-90. https://doi.org/10.1034/j.1399-6576.2000.440311.x
  30. Pollock JE, Liu SS, Neal JM, Stephenson CA. Dilution of spinal lidocaine does not alter the incidence of transient neurologic symptoms. Anesthesiology 1999; 90: 445-50. https://doi.org/10.1097/00000542-199902000-00019
  31. Hampl KF, Heinzmann-Wiedmer S, Luginbuehl I, Harms C, Seeberger M, Schneider MC, et al. Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology 1998; 88: 629-33. https://doi.org/10.1097/00000542-199803000-00012
  32. Rainin EA, Carlson BM. Postoperative diplopia and ptosis. A clinical hypothesis based on the myotoxicity of local anesthetics. Arch Ophthalmol 1985; 103: 1337-9. https://doi.org/10.1001/archopht.1985.01050090089038
  33. Blum RA, Lim LT, Weir CR. Diplopia following sub-tenon's anaesthesia: an unusual complication. Int Ophthalmol 2012; 32: 191-3. https://doi.org/10.1007/s10792-012-9535-3
  34. Choi YK, Liu J. The use of 5% lidocaine for prolonged analgesia in chronic pain patients: a new technique. Reg Anesth Pain Med 1998; 23: 96-100.

Cited by

  1. Comparison of the efficacy and safety of 2% lidocaine HCl with different epinephrine concentration for local anesthesia in participants undergoing surgical extraction of impacted mandibular third molars vol.96, pp.21, 2017, https://doi.org/10.1097/MD.0000000000006753
  2. Effects of an Intraparenchymal Injection of Lidocaine in the Rat Cervical Spinal Cord vol.43, pp.11, 2018, https://doi.org/10.1007/s11064-018-2628-2
  3. Prolongation of greater occipital neural blockade with 10% lidocaine neurolysis: a case series of a new technique vol.9, pp.None, 2016, https://doi.org/10.2147/jpr.s112947